Urinary sodium/creatinine ratio is a predictor for fractional sodium excretion and related to age in patients with cystic fibrosis.

Adults Children Cystic fibrosis Fractional sodium excretion Salt Sodium Sodium status sodium depletion

Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
03 2022
Historique:
received: 23 04 2021
revised: 03 11 2021
accepted: 04 11 2021
pubmed: 23 11 2021
medline: 14 4 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

Electrolyte disturbances are common in patients with cystic fibrosis (CF). Current guidelines on monitoring sodium status are based on research in a small group of infants and require blood sampling. The aim of this study was to evaluate urinary salt parameters as a surrogate for sodium-status in different age-groups. Blood and urine samples for electrolytes were collected from 222 patients followed at the Ghent University Hospital CF-center. Fractional sodium excretion (FENa) and several urinary parameters were calculated. Clinical characteristics did not differ according to sodium status, defined as FENa <0.5%. ROC analysis demonstrated that sodium/creatinine ratio (UNa/Creat) predicted the sodium status most accurately with high sensitivity and specificity (97 and 91% respectively). The UNa/Creat cut-off predicting a FENa <0.5% differed significantly according to age. The UNa/Creat is an excellent marker for the sodium status defined as a FENa <0.5%. However, different cut-offs according to age category should be applied.

Identifiants

pubmed: 34802939
pii: S1569-1993(21)02130-5
doi: 10.1016/j.jcf.2021.11.002
pii:
doi:

Substances chimiques

Sodium Chloride 451W47IQ8X
Sodium 9NEZ333N27
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e136-e140

Informations de copyright

Copyright © 2021 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None of the authors have a conflict of interest.

Auteurs

Dimitri Declercq (D)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Center for Nutrition and Dietetics, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium. Electronic address: Dimitri.declercq@uzgent.be.

Lieselot Peremans (L)

Ghent University, Faculty of medicine and health sciences, C. Heymanslaan 10, Gent, Belgium.

Michiel Glorieus (M)

Ghent University, Faculty of medicine and health sciences, C. Heymanslaan 10, Gent, Belgium.

Yannick Vande Weygaerde (YV)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Department of Respiratory Medicine, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Heidi Schaballie (H)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Department of Paediatric Respiratory Medicine, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Eva Van Braeckel (E)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Department of Respiratory Medicine, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Evelien Snauwaert (E)

Department of Paediatric Nephrology, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Sabine Van Daele (S)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Department of Paediatric Respiratory Medicine, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Stephanie Van Biervliet (S)

Cystic Fibrosis Reference Center, Ghent University Hospital, C. Heymanslaan 10, Belgium; Department of Paediatric gastroenterology, Ghent University Hospital, C. Heymanslaan 10, Gent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH